Nahdi Medical Co.’s shareholders approved several key resolutions, including the transfer of the statutory reserve balance of SAR 369.21 million—per the financial statements for the year ended Dec. 31, 2024—into retained earnings.
This came during the extraordinary general meeting (EGM) held yesterday, April 30.
According to a statement to Tadawul, shareholders also authorized the board of directors to distribute interim dividends on a semi-annual or quarterly basis for 2025.
Additionally, shareholders approved a total remuneration of SAR 3.5 million for board members for the fiscal year ended Dec. 31, 2024.